ISPO

Angiogenesis

A quantitative assay using basement membrane extracts to study angiogenesis in vivo

Y Iwamoto MD PhD , Y Ito MD PhD

Oncogenic potential of Human Cytomegalovirus: Influence on expression of Thrombospondin-1 independent of tumour suppressor protein p53

JU Vogel PhD, R Kachatkou MD, J Cinatl MD PhD, P Hernàiz Driever MD, B Kornhuber MD, HW Doerr MD, J Cinatl Jr. PhD

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endo-thelial growth factor (rhuMabVEGF) in combination with chemotherapy (ChRx) in patients with advanced cancer (CA)

K.Margolin, M.S. Gordon, M. Talpax, G. Fyfe, W. Novotny, D. Adelman, J. Breed

Angiogenic factors gene expression and tumor angiogenesis in larynx, breast and lung carcinomas

D. Vitolo, L. Ciocci, P. Ferrauti, C. Rossi, F. Tiboni, R. Cieerone and C.D. Baroni.

Fibronectin in the developing corpus luteum of rats: Neovascularization and extracellular matrices

T Matsushima MD , K Tsukada MD

Clinical roles of vascular endothelial growth factor (VEGF) expression in gastric cancer

T Nakamura MD, T Kuniyasu MD, M Ohno MD, Y Iwatani, Y Suzuki, H Shinmaru, T Sakakibara MD, Y Kuroda MD, Y Tabuchi MD

Inhibition of angiogenesis and protection from apoptosis by N-acetylcysteine (NAC)

G Fassina PhD , D Giunciuglio PhD , MG Aluigi PhD , T Cai , L Masiello , F D'agostino MD , S DeFlora MD and A Albini PhD .

A synthesized retinoid TAC-101 is an orally active antiangiogenic agent

T Oikawa PhD, K Murakami BS , M Sano BS , J Shibata MS , K Wierzba PhD , K Shudo PhD , K Tanaka PhD, Y Yamada PhD

Tamoxifen inhibits several steps in the angio-genesis cascade

AR Gagliardi MD PhD , RK Munn MD , P Nickel PhD , DC Collins PhD